Freedman N J, Liggett S B, Drachman D E, Pei G, Caron M G, Lefkowitz R J
Howard Hughes Medical Institute, Department of Medicine (Cardiology), Duke University Medical Center, Durham, North Carolina 27710, USA.
J Biol Chem. 1995 Jul 28;270(30):17953-61. doi: 10.1074/jbc.270.30.17953.
Persistent stimulation of the beta 1-adrenergic receptor (beta 1AR) engenders, within minutes, diminished responsiveness of the beta 1 AR/adenylyl cyclase signal transduction system. This desensitization remains incompletely defined mechanistically, however. We therefore tested the hypothesis that agonist-induced desensitization of the beta 1AR (like that of the related beta 2AR) involves phosphorylation of the receptor itself, by cAMP-dependent protein kinase (PKA) and the beta-adrenergic receptor kinase (beta ARK1) or other G protein-coupled receptor kinases (GRKs). Both Chinese hamster fibroblast and 293 cells demonstrate receptor-specific desensitization of the beta 1 AR within 3-5 min. Both cell types also express beta ARK1 and the associated inhibitory proteins beta-arrestin-1 and beta-arrestin-2, as assessed by immunoblotting. Agonist-induced beta 1AR desensitization in 293 cells correlates with a 2 +/- 0.3-fold increase in phosphorylation of the beta 1AR, determined by immunoprecipitation of the beta 1AR from cells metabolically labeled with 32P(i). This agonist-induced beta 1AR phosphorylation derives approximately equally from PKA and GRK activity, as judged by intact cell studies with kinase inhibitors or dominant negative beta ARK1 (K220R) mutant overexpression. Desensitization, likewise, is reduced by only approximately 50% when PKA is inhibited in the intact cells. Overexpression of rhodopsin kinase, beta ARK1, beta ARK2, or GRK5 significantly increases agonist-induced beta 1AR phosphorylation and concomitantly decreases agonist-stimulated cellular cAMP production (p < 0.05). Furthermore, purified beta ARK1, beta ARK2, and GRK5 all demonstrate agonist-dependent phosphorylation of the beta 1AR. Consistent with a GRK mechanism, receptor-specific desensitization of the beta 1AR was enhanced by overexpression of beta-arrestin-1 and -2 in transfected 293 cells. We conclude that rapid agonist-induced desensitization of the beta 1AR involves phosphorylation of the receptor by both PKA and at least beta ARK1 in intact cells. Like the beta 2AR, the beta 1AR appears to bind either beta-arrestin-1 or beta-arrestin-2 and to react with rhodopsin kinase, beta ARK1, beta ARK2, and GRK5.
对β1 - 肾上腺素能受体(β1AR)的持续刺激在数分钟内会使β1AR/腺苷酸环化酶信号转导系统的反应性降低。然而,这种脱敏作用在机制上仍未完全明确。因此,我们检验了这样一个假设,即激动剂诱导的β1AR脱敏作用(类似于相关的β2AR)涉及受体自身的磷酸化,这是由环磷酸腺苷(cAMP)依赖性蛋白激酶(PKA)、β - 肾上腺素能受体激酶(βARK1)或其他G蛋白偶联受体激酶(GRKs)介导的。中国仓鼠成纤维细胞和293细胞在3 - 5分钟内均表现出β1AR的受体特异性脱敏作用。通过免疫印迹评估,这两种细胞类型均表达βARK1以及相关的抑制蛋白β - 抑制蛋白 - 1和β - 抑制蛋白 - 2。293细胞中激动剂诱导的β1AR脱敏作用与β1AR磷酸化增加2±0.3倍相关,这是通过从用32P(i)进行代谢标记的细胞中免疫沉淀β1AR来确定的。通过使用激酶抑制剂或显性负性βARK1(K220R)突变体过表达的完整细胞研究判断,这种激动剂诱导的β1AR磷酸化大约同样源自PKA和GRK活性。同样,当在完整细胞中抑制PKA时,脱敏作用仅降低约50%。视紫红质激酶、βARK1、βARK2或GRK5的过表达显著增加激动剂诱导的β1AR磷酸化,并同时降低激动剂刺激的细胞内cAMP产生(p < 0.05)。此外,纯化的βARK1、βARK2和GRK5均显示出激动剂依赖性的β1AR磷酸化。与GRK机制一致,在转染的293细胞中,β - 抑制蛋白 - 1和 - 2的过表达增强了β1AR的受体特异性脱敏作用。我们得出结论,在完整细胞中,激动剂快速诱导的β1AR脱敏作用涉及PKA以及至少βARK1对受体的磷酸化。与β2AR一样,β1AR似乎能结合β - 抑制蛋白 - 1或β - 抑制蛋白 - 2,并与视紫红质激酶、βARK1、βARK2和GRK5发生反应。